Valuation: Tristel plc

Market Cap 195M 261M 234M 215M 364M 24.77B 371M 2.56B 1.03B 13.03B 979M 958M 41.09B P/E 2026
24.1x
P/E 2027 * 22.2x
Enterprise Value 185M 248M 222M 204M 346M 23.55B 352M 2.44B 978M 12.39B 931M 911M 39.06B EV / Sales 2026
3.44x
EV / Sales 2027 * 3.22x
Free-Float
93.07%
Yield 2026
3.73%
Yield 2027 * 3.87%
1 week+3.85%
Current month-1.22%
3 months-3.57%
6 months+1.89%
Current year-2.99%
1 week 395
Extreme 395
415
1 month 385
Extreme 385
445
Current year 350
Extreme 350
450
1 year 350
Extreme 350
450
3 years 260
Extreme 260
510
5 years 260
Extreme 260
510
10 years 143.94
Extreme 143.94
680
Manager TitleAgeSince
Chief Executive Officer 64 01/08/2026
Director of Finance/CFO - 01/01/2025
Chief Executive Officer - 30/06/2026
Director TitleAgeSince
Director/Board Member 54 19/10/2017
Chairman 65 17/12/2019
Director/Board Member 68 27/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
23/3/26 Buy

Director

2,597 0.0054%
3/3/26 Buy

Director

770 0.0016%
3/3/26 Buy

Director

1,540 0.0032%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+3.85%+12.50%+1.25% 260M
+1.56%+2.41%-14.82%+14.19% 181B
-6.38%-4.98%-20.90%+11.15% 120B
-0.59%+1.18%+6.12%+37.97% 119B
+3.42%+4.04%-42.10%+9.69% 91.44B
+0.09%-0.05%-3.04%+78.44% 63.07B
-0.46%-0.64%+9.87%+80.82% 55.8B
-0.23%-0.52%+10.31%-21.19% 54.03B
-4.30%-1.64%-12.30%+39.06% 45.38B
+0.58%+2.18%-0.54%-6.40% 34.37B
Average -0.63%+0.82%-5.49%+24.50% 76.37B
Weighted average by Cap. -0.58%+0.76%-10.42%+25.10%

Financials

2026 2027 *
Net sales 51.18M 68.56M 61.4M 56.48M 95.66M 6.51B 97.45M 674M 270M 3.42B 257M 252M 10.8B 56.11M 75.18M 67.33M 61.93M 105M 7.14B 107M 739M 296M 3.75B 282M 276M 11.84B
Net income 7.93M 10.63M 9.52M 8.76M 14.83M 1.01B 15.11M 104M 41.91M 531M 39.88M 39.04M 1.67B 8.85M 11.85M 10.62M 9.76M 16.54M 1.13B 16.85M 116M 46.74M 592M 44.48M 43.54M 1.87B
Net Debt -9.59M -12.84M -11.5M -10.58M -17.92M -1.22B -18.25M -126M -50.65M -641M -48.2M -47.17M -2.02B -14.27M -19.11M -17.12M -15.75M -26.67M -1.81B -27.17M -188M -75.38M -955M -71.73M -70.21M -3.01B
Projected Income Statement - Annual - Tristel plc
Logo Tristel plc
Tristel plc is a United Kingdom-based infection prevention company. The Company's core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The Company operates through three segments: Hospital medical device decontamination, Hospital environmental surface disinfection and others. It manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. It addresses pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal (GI) physiology, laboratory, ophthalmology, and ultrasound.
Employees
282
Date Price Change Volume
30/10/26 GBX 405.00 0.00% 69,244
29/10/26 GBX 405.00 0.00% 55,844
28/10/26 GBX 405.00 -0.61% 32,963
27/10/26 GBX 407.50 0.00% 233,675
26/10/26 GBX 407.50 +1.24% 93,402
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Tristel plc
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
4.050GBP
Average target price
4.707GBP
Spread / Average Target
+16.21%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Tristel plc
  1. Stock Market
  2. Stocks
  3. TSTL Stock